The warning signs of what would become a deadly opioid epidemic emerged in early 2001. That’s when officials of the state employee health plan in West Virginia noticed a surge in deaths attributed to oxycodone, the active ingredient in the painkiller OxyContin

Quick Read

Another pharmaceutical company is coming under fire for boosting the price of one of its drugs. Two lawmakers are demanding to know the justification for a more than $80,000 price hike for a year’s supply of a drug that treats leukemia patients

Quick Read

The Affordable Care Act prohibits insurers from discriminating against people with serious illnesses, but some marketplace plans sidestep that taboo by making the drugs that people with HIV need unavailable or unaffordable, complaints filed recently with the Department of Health and Human Services’ Office for Civil Rights allege

Quick Read

An overwhelming majority of Americans favor government action to restrain prescription drug prices, according to a poll released Thursday

Quick Read

The medical maker collective Four Thieves Vinegar made an “EpiPencil” for a tiny fraction of what the EpiPen manufacturer Mylan charges

Quick Read

Against a growing outcry over the surging price of EpiPens, a chorus of prominent voices has emerged with a smart-sounding solution: Add the EpiPen, the lifesaving allergy treatment, to a federal list of preventive medical services, a move that would eliminate the out-of-pocket costs of the product for millions of families — and mute the protests

Quick Read

Oooh, it was going to be so good for women. It was going to bring back our flagging mojos en masse, save slumping relationships, and, if that weren’t enough, rectify what some were calling “persistent gender bias” at the FDA

Quick Read

Controversial US guidelines attempt to rein in rogue stem-cell clinics

Quick Read